Mitomycin C-induced hemolytic uremic syndrome. Six casereports and review of the literature on renal, pulmonary and cardiac side effects of the drug
- 1 January 1987
- journal article
- review article
- Published by Elsevier in Radiotherapy and Oncology
- Vol. 8 (1) , 33-41
- https://doi.org/10.1016/s0167-8140(87)80020-8
Abstract
No abstract availableKeywords
This publication has 44 references indexed in Scilit:
- Combination chemotherapy with doxorubicin and mitomycin C in non small cell bronchogenic carcinomaAmerican Journal of Clinical Oncology, 1984
- Microangiopathic hemolytic anemia, a frequent complication of mitomycin therapy in cancer patientsEuropean Journal of Cancer and Clinical Oncology, 1984
- An interim report of a prospective, randomized, controlled study of adjuvant chemotherapy in operable gastric cancer: British stomach cancer groupWorld Journal of Surgery, 1983
- An effective low-dose mitomycin regimen for hormonal- and chemotherapy-refractory patients with metastatic breast cancerCancer, 1983
- Haemolytic-uraemic syndrome complicating long-term mitomycin C and 5-fluorouracil therapy for gastric carcinoma.Journal of Clinical Pathology, 1983
- Mitomycin C und hochdosiertes Medroxyprogesteronacetat in der Therapie des metastasierenden MammakarzinomsOncology Research and Treatment, 1982
- Pulmonary toxicity of mitomycinCancer, 1980
- Mitomycin and Interstitial PneumonitisAnnals of Internal Medicine, 1979
- Interstitial lung disease in a patient treated with 5-fluorouracil and mitomycin C.BMJ, 1978
- Mitomycin C: a reviewCancer Treatment Reviews, 1976